Greg Powell

Director, Safety Evaluation and Risk Management GlaxoSmithKline

Greg PowellGreg Powell is the Director in Global Clinical Safety and Pharmacovigilance group at GlaxoSmithKline and has over 25 years of pharmaceutical experience with the last 12 years specifically focused on drug safety innovation. Additionally, he is an adjunct assistant professor at the UNC Echelman School of Pharmacy and has a PharmD from the University of Florida.